FR2803750B1 - Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant - Google Patents

Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant

Info

Publication number
FR2803750B1
FR2803750B1 FR0000550A FR0000550A FR2803750B1 FR 2803750 B1 FR2803750 B1 FR 2803750B1 FR 0000550 A FR0000550 A FR 0000550A FR 0000550 A FR0000550 A FR 0000550A FR 2803750 B1 FR2803750 B1 FR 2803750B1
Authority
FR
France
Prior art keywords
atrophyant
dehydroepiandrosterone
oral use
metabolic derivatives
biological precursors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0000550A
Other languages
English (en)
Other versions
FR2803750A1 (fr
Inventor
La Charriere Olivier De
Stephanie Nouveau
Francoise Forette
Etienne Emile Baulieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Priority to FR0000550A priority Critical patent/FR2803750B1/fr
Publication of FR2803750A1 publication Critical patent/FR2803750A1/fr
Application granted granted Critical
Publication of FR2803750B1 publication Critical patent/FR2803750B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FR0000550A 2000-01-17 2000-01-17 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant Expired - Fee Related FR2803750B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0000550A FR2803750B1 (fr) 2000-01-17 2000-01-17 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0000550A FR2803750B1 (fr) 2000-01-17 2000-01-17 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant

Publications (2)

Publication Number Publication Date
FR2803750A1 FR2803750A1 (fr) 2001-07-20
FR2803750B1 true FR2803750B1 (fr) 2004-04-02

Family

ID=8845990

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0000550A Expired - Fee Related FR2803750B1 (fr) 2000-01-17 2000-01-17 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant

Country Status (1)

Country Link
FR (1) FR2803750B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1807062A4 (fr) * 2004-11-01 2009-06-03 Endorech Inc Utilisation d'androgenes pour retarder le vieillissement de la peau ou traiter celui-ci

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2619505B1 (fr) * 1987-08-20 1990-08-31 Dior Christian Parfums Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
FR2663850B1 (fr) * 1990-07-02 1994-01-14 Gird Galderma Composition pharmaceutique ou cosmetique contenant en association un retinouide et un sterol.
US5922701A (en) * 1992-05-01 1999-07-13 University Of Utah Research Foundation Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
CN1100541C (zh) * 1993-01-19 2003-02-05 恩多研究公司 脱氢表雄酮的治疗用途和传送系统
US5846963A (en) * 1995-06-07 1998-12-08 University Of Utah Research Foundation Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
EP0908183A1 (fr) * 1997-10-08 1999-04-14 Institute For Advanced Skin Research Inc. Déhydroépiandrostérone ou ses dérivés pour augmenter la quantité d'acide hyaluronique dans la peau
AU4127499A (en) * 1998-06-11 1999-12-30 Endorecherche Inc. Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta-diol

Also Published As

Publication number Publication date
FR2803750A1 (fr) 2001-07-20

Similar Documents

Publication Publication Date Title
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
EE05169B1 (et) Asendatud oksasolidinoonid ja nende kasutamine
AU2001275860A1 (en) Surgical prep solution applicator system and methods
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
AR038207A1 (es) Composicion farmaceutica dispersable oralmente de agomelatina
DE60018495D1 (de) Tamponeinführhilfe
DE60018142D1 (de) Tamponapplikator
DE50001690D1 (de) Chirurgisches Cerclageband
ATE455754T1 (de) Arylsulfonamid-substituierte hydroxamsäure- derivate
ES1044448Y (es) Auto-aplicador de vendaje
DK1330258T3 (da) Kahalalid F-formulering
DE60038118D1 (de) Formulierungen von wachstumshormonen
DE60025251D1 (de) Tamponapplikator
PT1214302E (pt) 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao como inibidores de lipase
NO20021452D0 (no) Orale kontrollerte frigivelsesformuleringer
FR2803750B1 (fr) Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
FR2828064B1 (fr) Utilisation de derives terpeniques comme agent anti-rebond augmentant la retention
MA25814A1 (fr) Derives de 2-aminothiazoline et leur utilisation comme inhibiteurs de no-synthase.
DE60331556D1 (de) Beschichtete kapillar-elektrophoreseröhren und system
FR2803518B1 (fr) Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives metaboliques comme regulateurs de la pigmentation
ITMI992048A0 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabi cicloalcani
PT1373249E (pt) Derivados de imidazolidina, sua preparacao e sua utilizacao como agente anti-inflamatorio
IT1308959B1 (it) Dispositivo di autotrasfusione post-operatoria particolarmente incardiochirurgia
FR2803519B1 (fr) Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130930